Brief: Egetis Decides To Explore RTH-Beta As Next Indication For Tiratricol (Emcitate)

Egetis Therapeutics AB (publ)

04/12/2024 07:04

Dec 4 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS HAS DECIDED TO EXPLORE RTH-BETA AS THE NEXT
INDICATION
FOR TIRATRICOL (EMCITATE®)

Source text:  ID:nMFNncnc4 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))